bisindolylmaleimide i has been researched along with Diabetes Mellitus, Type 1 in 2 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vetri, F | 1 |
| Qi, M | 1 |
| Xu, H | 1 |
| Oberholzer, J | 1 |
| Paisansathan, C | 1 |
| Hyun, E | 1 |
| Ramachandran, R | 1 |
| Cenac, N | 1 |
| Houle, S | 1 |
| Rousset, P | 1 |
| Saxena, A | 1 |
| Liblau, RS | 1 |
| Hollenberg, MD | 1 |
| Vergnolle, N | 1 |
2 other studies available for bisindolylmaleimide i and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Impairment of neurovascular coupling in Type 1 Diabetes Mellitus in rats is prevented by pancreatic islet transplantation and reversed by a semi-selective PKC inhibitor.
Topics: Animals; Arterioles; Benzimidazoles; Cardiovascular Agents; Diabetes Mellitus, Experimental; Diabete | 2017 |
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response.
Topics: Animals; Calcium; Cell Line; Cells, Cultured; Chromones; Diabetes Mellitus, Type 1; Endothelial Cell | 2010 |